Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Fuminori Ota"'
Autor:
Takuya Ohashi, Mitsumasa Kawago, Fuminori Ota, Yoshimitsu Hirai, Megumi Kiyoi, Miwako Miyasaka, Yumi Yata, Mari Kawaji, Aya Fusamoto, Hideto Iguchi, Hitomi Nakanishi, Takahito Nakaya, Yuki Fujiwara, Yoshiharu Nishimura
Publikováno v:
Journal of Surgical Case Reports. 2022
Descending necrotizing mediastinitis (DNM) is a severe, life-threatening disease and requires prompt treatment. The primary treatment for DNM is cervical and mediastinal drainage in addition to antibiotic treatment. However, the most appropriate drai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2fc56746ce005addb3951d46c4a51ad
https://doi.org/10.1093/jscr/rjac237
https://doi.org/10.1093/jscr/rjac237
Autor:
Yumi Tanaka, Yoshitaka Okamura, Fuminori Ota, Shoji Oura, Yoshimitsu Hirai, Tatsuya Yoshimasu
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 27:79-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95538caf198d669879ae7b06663fed61
https://doi.org/10.2995/jacsurg.27.79
https://doi.org/10.2995/jacsurg.27.79
Autor:
Yoshimitsu Hirai, Fuminori Ota, Megumi Kiyoi, Koma Naito, Yoshitaka Okamura, Tatsuya Yoshimasu
Publikováno v:
The Journal of the Japanese Associtation for Chest Surgery. 22:933-938
術前血清KL-6値が高値を示した大腸癌肺転移の2例を経験した．症例1：75歳男性．直腸癌術後follow-up中，血清CEA値の上昇と胸部CTの異常陰影を指摘された．術前KL-6値1800 U/ml．2005年6月，胸腔
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::938574787fd2ed5296a56b22c53211dd
https://doi.org/10.2995/jacsurg.22.933
https://doi.org/10.2995/jacsurg.22.933
Autor:
Rie Nakamura, Megumi Kiyoi, Shoji Oura, Yoshimitsu Hirai, Takeshi Tamaki, Fuminori Ota, Yoshitaka Okamura, Koma Naito, Tatsuya Yoshimasu, Yukio Shimizu, Mitsumasa Kawago
Publikováno v:
The Journal of the Japanese Associtation for Chest Surgery. 21:882-885
非小細胞肺癌術後補助化学療法として，paclitaxel単剤による治療が選択された症例についてretrospectiveにその有用性を検討した．対象と方法：2001～2006年の手術例のうち19例でpaclitaxel単剤に
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::718b142392dbfd94cc6c987a7f4ac012
https://doi.org/10.2995/jacsurg.21.882
https://doi.org/10.2995/jacsurg.21.882
Autor:
Shoji Oura, Tatsuya Yoshimasu, Hirokazu Tanino, Fuminori Ota, Teruhisa Sakurai, Yoshitaka Okamura, Yozo Kokawa, Kenji Matsuyama
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 16:640-644
症例は33歳の男性.1994年10月11日, 胸腺腫にて手術を施行された.術後follow-up中の1999年12月, 胸部CTにて, 多発性の胸膜播種巣を発見された.同時期に重症筋無力症を発症した.ステロイド治療に
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21debdb09b9a0e05e4e8919b19f0b12c
https://doi.org/10.2995/jacsurg.16.5_640
https://doi.org/10.2995/jacsurg.16.5_640
Autor:
Fuminori Ota, Tsuneaki Sakuraba, Nanami Asai, Kazuyoshi Arai, Ryo Koroki, Miho Minato, Kenichi Tokieda
Publikováno v:
The Proceedings of the Symposium on sports and human dynamics. 2017:C-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcfb136917afd82a788e95a534c31206
https://doi.org/10.1299/jsmeshd.2017.c-15
https://doi.org/10.1299/jsmeshd.2017.c-15
Autor:
Shoji Oura, Yoshitaka Okamura, Takahiko Ishigaki, Yoshimitu Hirai, Fuminori Ota, Tatsuya Yoshimasu, Rie Nakamura
Publikováno v:
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia. 19(5)
Purpose We retrospectively reviewed our experience of surgical resection for second primary lung cancer (SPLC) in our institute. And to clarify whether periodic follow-up after resection of first primary lung cancer (FPLC) is associated with earlier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ea3893eaa4a01c48ab96ec03983678
https://pubmed.ncbi.nlm.nih.gov/23237928
https://pubmed.ncbi.nlm.nih.gov/23237928
Autor:
Yoshimitsu, Hirai, Yukio, Shimizu, Shoji, Oura, Tatsuya, Yoshimasu, Fuminori, Ota, Rie, Nakamura, Koma, Naito, Haruka, Nishiguchi, Sayoko, Hashimoto, Yoshitaka, Okamura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(3)
A previous large, randomized, control trial(JBR.10)revealed that adjuvant chemotherapy with cisplatin(CDDP) and vinorelbine(VNR)was effective for non-small-cell lung cancer(NSCLC). It was also reported that adjuvant chemotherapy was not effective for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fff487d6dabbe911b4a44d1a24c0e1f
https://pubmed.ncbi.nlm.nih.gov/22421763
https://pubmed.ncbi.nlm.nih.gov/22421763
Autor:
Yumi Tanaka, Koma Naito, Fuminori Ota, Yoshimitsu Hirai, Rie Nakamura, Tatsuya Yoshimasu, Yoshitaka Okamura, Shoji Oura, Masako Ikeda, Mitsumasa Kawago
Publikováno v:
Journal of Pulmonary & Respiratory Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1ab7dd7d6dc0298071ffa3aab095c46
https://doi.org/10.4172/2161-105x.1000118
https://doi.org/10.4172/2161-105x.1000118
Autor:
Yoshimitsu, Hirai, Tatsuya, Yoshimasu, Shoji, Oura, Fuminori, Ota, Koma, Naito, Haruka, Nishiguchi, Sayoko, Hashimoto, Yoshitaka, Okamura
Publikováno v:
Anticancer research. 31(3)
To clarify whether class III β-tubulin (TUBB3) is a true predictive marker for chemotherapy with vinorelbine, chemosensitivity was examined using an in vitro drug sensitivity assay.Initially, 9 specimens were obtained to analyze the dose-response cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9e0389962c785ec08f4ed50c553a380
https://pubmed.ncbi.nlm.nih.gov/21498728
https://pubmed.ncbi.nlm.nih.gov/21498728